Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
3 Dividend Stocks to Buy If You're Worried About the Stock Market
05:55am, Sunday, 05'th Sep 2021
You can invest in these solid stocks with a peace of mind.
4 Market-Topping Dividend Stocks That Can Double Your Money by 2026
06:06am, Saturday, 04'th Sep 2021
With yields ranging from 2.3% to 10.1%, these income stocks can quickly build wealth for investors.
Viatris: This May Be The Perfect Time To Buy
01:13am, Thursday, 02'nd Sep 2021
Viatris: This May Be The Perfect Time To Buy
Why Viatris Is Growth At A Reasonable Price
10:33pm, Wednesday, 01'st Sep 2021
Why Viatris Is Growth At A Reasonable Price
Dividend Stock Watch List: Lanny's September 2021 Edition
02:30pm, Tuesday, 31'st Aug 2021
As we've seen in the housing market, Home Depot and Lowe's may be seeing a slow-down in growth right now.
Richard Pzena's Firm Adds to NPR Energy, Axes Viatris
06:18pm, Wednesday, 25'th Aug 2021
Pzena Investment Management recently disclosed its 13F portfolio updates for the second quarter of 2021, which ended on June 30.
Analysts Love This Newly Formed Healthcare Company; Should You?
11:01am, Monday, 16'th Aug 2021
Viatris' steady operating results and cheap valuation are two key reasons for its high one-year price target.
Dividend Stock Purchase: Lanny's July 2021 Summary
07:01pm, Tuesday, 10'th Aug 2021
Dividend Stock Purchase: Lanny's July 2021 Summary
Viatris Inc. (VTRS) CEO Michael Goettler on Q2 2021 Results - Earnings Call Transcript
02:55pm, Monday, 09'th Aug 2021
Viatris Inc. (VTRS) CEO Michael Goettler on Q2 2021 Results - Earnings Call Transcript
Viatris (VTRS) Beats on Q2 Earnings & Sales, Raises View
11:35am, Monday, 09'th Aug 2021
Viatris (VTRS) beats on Q2 earnings and sales. The company raises annual guidance.
Viatris Reports Strong Second Quarter Results
06:59am, Monday, 09'th Aug 2021
PITTSBURGH, Aug. 9, 2021 /PRNewswire/ -- Reports Second Quarter 2021 Financial Results - Total Revenues of $4.58 billion, U.S. GAAP Net Loss of $279 million, Adjusted EBITDA of $1.68 billion, U.S. G
How This Historic FDA Approval Benefits Viatris
08:21am, Wednesday, 04'th Aug 2021
Here's what the FDA's approval of Semglee, from Viatris and Biocon, means for the former.
Amid the Rise of the Delta Variant, Here's My Top Coronavirus Vaccine Stock to Buy
09:12am, Saturday, 31'st Jul 2021
Hint: You may have heard a lot about this company in the past year.
Viatris (VTRS) Dips More Than Broader Markets: What You Should Know
06:59pm, Friday, 30'th Jul 2021
Viatris (VTRS) closed at $14.07 in the latest trading session, marking a -1.57% move from the prior day.
2021 Top Idea Contest - New Ideas
11:53am, Thursday, 29'th Jul 2021
Today, we have our "Double Down or Diversify" series. We have 13 new ideas that contributors have chosen for the second half of the contest.
